paraquat has been researched along with edaravone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, Y; Onishi, S; Ono, M; Saibara, T; Toda, K; Wakatsuki, A | 1 |
| Qian, X; Sun, H; Yang, L; Zhi, Q | 1 |
| Kong, X; Li, Q; Liu, L; Liu, X; Long, X; Shi, B; Wang, T; Xiong, N | 1 |
| Shinan, N; Wei, Z; Xin, C; Yi, R; Zhaorui, S; Zhizhou, Y | 1 |
4 other study(ies) available for paraquat and edaravone
| Article | Year |
|---|---|
Protective effect of 3-methyl-1-phenyl-2-pyrazolin-5-one, a free radical scavenger, on acute toxicity of paraquat in mice.
Topics: Animals; Antipyrine; Dose-Response Relationship, Drug; Edaravone; Free Radical Scavengers; Herbicides; Male; Mice; Paraquat; Proportional Hazards Models; Survival; Time Factors | 2003 |
Edaravone, a novel antidote against lung injury and pulmonary fibrosis induced by paraquat?
Topics: Animals; Antidotes; Antipyrine; Bronchoalveolar Lavage Fluid; Edaravone; Herbicides; Hydroxyproline; Lung; Lung Injury; Male; Paraquat; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2011 |
Combined edaravone and D1-3-n-butylphthalide antioxidant therapy for paraquat poisoning.
Topics: Adult; Antioxidants; Antipyrine; Benzofurans; Drug Therapy, Combination; Edaravone; Emergency Service, Hospital; Humans; Male; Paraquat | 2014 |
Retrospective study of clinical features and prognosis of edaravone in the treatment of paraquat poisoning.
Topics: Adult; Biomarkers; Cytokines; Edaravone; Female; Humans; Male; Oxidative Stress; Paraquat; Prognosis; Protective Agents; Pulmonary Fibrosis; Retrospective Studies | 2019 |